heat News and Research

RSS

Heat therapy using Thermomed device effective for treatment of leishmaniasis

A single session of heat therapy using the Thermomed™ device appears to be as effective as a 10-day intravenous course of sodium stibogluconate (Pentostam) for the treatment of Leishmania major skin lesions, according to a new study by Naomi Aronson and her colleagues at the Uniformed Services University of the Health Sciences and Walter Reed Army Medical Center.

9 Mar 2010

Nanoparticles: Targeted cancer therapy

Another weapon in the arsenal against cancer: Nanoparticles that identify, target and kill specific cancer cells while leaving healthy cells alone.

9 Mar 2010

Core Essence Orthopaedics to showcase advances in implant technology at 2010 Hand Surgery Symposium

Core Essence Orthopaedics, Inc., an innovative medical device company focused on minimally invasive soft tissue and skeletal repair solutions (for the extremities), will be attending the 12th Annual Hand Surgery Symposium in Philadelphia.

8 Mar 2010

Research group performs randomized study to evaluate efficacy of ICCBco in treatment of lung lesions

To evaluate efficacy of Calculus Bovis compound preparation (ICCBco) in the treatment of lung lesions in portal hypertensive rabbits with schistosomiasis as the experimental animal model, a research group in China performed a randomized, double-blind, controlled trial to observe pathological changes and pathological effect mechanism of expression of fibronectin and laminin in the lung tissue of portal hypertensive rabbits with schistosomiasis.

6 Mar 2010

Overview of nanotechnology: Nanoparticles may eventually be used in cosmetic products

The rapidly growing field of nanotechnology and its future use in cosmetic products holds both enormous potential and potential concern for consumers. Currently, major cosmetic manufacturers have imposed a voluntary ban on the use of nanoparticles in products while they await a ruling from the Food and Drug Administration regarding the safety of this technology.

5 Mar 2010

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

The second American Association for Cancer Research Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic provides attendees with an overview of the most advanced cancer research in a variety of fields, including the tumor microenvironment, microRNAs, signal transduction and novel therapeutic development.

5 Mar 2010

Proper diagnosis, treatment and good skin care help control acne and rosacea

Acne and rosacea are two seemingly different skin conditions that have one important thing in common: both are chronic and extremely common skin conditions. However, dermatologists recommend that with proper diagnosis, treatment and a healthy dose of good, old-fashioned skin care, acne and rosacea can be less of a nuisance for patients.

5 Mar 2010

Political heat tests the President's calm composure

The Washington Post: For a president "who so famously rejects drama," recent times have marked "one of the wildest policitcal stretches in recent memory." President Obama has said during yesterday's White House speech that, at stake in this legislative struggle is the nation's ability not only to solve health care problems, but "our ability to solve any problem."

4 Mar 2010

Blood glucose-lowering hormone FGF21 also activates brown adipose tissue metabolism

The blood glucose-lowering hormone FGF21 is also an activator of brown adipose tissue metabolism, according to the study featured on the cover of Cell Metabolism and directed by the lecturer Francesc Villarroya of the UB's Department of Biochemistry and Molecular Biology (Faculty of Biology), the Institute of Biomedicine, and the Biomedical Research Networking Centre in Physiopathology of Obesity and Nutrition.

3 Mar 2010

Intercell AG's revenues for full year 2009 increase 10.6%

Today, the biotech-vaccine company Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2009, and presented an update on the Company's development programs.

2 Mar 2010

Consumption of garlic reduces level of potential carcinogenic processes

Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.

2 Mar 2010

First Edition: March 1, 2010

Today's headlines focus on Democratic vote-counting and what plans the future will hold for advancing health reform.

1 Mar 2010

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

1 Mar 2010

Overturning EPA's endangerment finding: American Public Health Association, leading health organizations oppose

The American Public Health Association yesterday joined a dozen leading health organizations in urging the U.S. Senate to oppose a resolution introduced by Sen. Lisa Murkowski to overturn or block the U.S. Environmental Protection Agency's finding for six greenhouse gases that contribute to climate change.

27 Feb 2010

Researchers develop noninvasive infrared scanning system to diagnose melanomas

Johns Hopkins researchers have developed a noninvasive infrared scanning system to help doctors determine whether pigmented skin growths are benign moles or melanoma, a lethal form of cancer.

27 Feb 2010

Focal therapy for localized prostate cancer: US HIFU announces intention to fund multi-center trial

US HIFU, a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 medical device, has announced its intention to fund a landmark multi-center trial to study focal therapy for localized prostate cancer. Mark Emberton, M.D., (FRCS-Urology), consultant urological surgeon and divisional clinical director of cancer services at University College London Hospital (UCLH), along with Hashim Uddin Ahmed, MRC clinical research fellow, will lead the trial.

25 Feb 2010

Unique technology identifies drug candidates, speeds up drug development

The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate.

From NanoTemper Technologies 24 Feb 2010

Smith & Nephew launches DYONICS RF System to remove soft tissue during arthroscopic surgery

Smith & Nephew's Endoscopy Division today announced the launch of the DYONICS™ RF System, which incorporates a compact generator with a family of probes for aggressively removing defects and smoothing soft tissue during arthroscopic surgery.

24 Feb 2010

IBM Maximo software helps GNL ensure optimal performance of equipment in fight against emerging infectious diseases

In the fight against emerging infectious diseases, The Galveston National Laboratory (GNL), one of two National Institutes of Health funded bio-containment laboratories in the United States, is benefiting from IBM software to ensure the optimal performance of all equipment functioning within its facility. The GNL, which is dedicated to the study and prevention of emerging infectious diseases, will use IBM Maximo Asset Management Software to help automate, manage and ensure the performance of its 3,000 operating assets in one of the world's most complex medical research environments.

24 Feb 2010

Researchers study how laser-induced ultrasound could help identify the stage of melanoma

Knowing the stage of a patient's melanoma is important when choosing the best course of treatment. When the cancer has progressed to the lymph nodes, a more aggressive treatment is needed. Examining an entire lymph node for cancer takes much effort and time; a new technique might help make the process more efficient.

24 Feb 2010

heat News and Research

Heat therapy using Thermomed device effective for treatment of leishmaniasis

Nanoparticles: Targeted cancer therapy

Core Essence Orthopaedics to showcase advances in implant technology at 2010 Hand Surgery Symposium

Research group performs randomized study to evaluate efficacy of ICCBco in treatment of lung lesions

Overview of nanotechnology: Nanoparticles may eventually be used in cosmetic products

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

Proper diagnosis, treatment and good skin care help control acne and rosacea

Political heat tests the President's calm composure

Blood glucose-lowering hormone FGF21 also activates brown adipose tissue metabolism

Intercell AG's revenues for full year 2009 increase 10.6%

Consumption of garlic reduces level of potential carcinogenic processes

First Edition: March 1, 2010

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

Overturning EPA's endangerment finding: American Public Health Association, leading health organizations oppose

Researchers develop noninvasive infrared scanning system to diagnose melanomas

Focal therapy for localized prostate cancer: US HIFU announces intention to fund multi-center trial

Unique technology identifies drug candidates, speeds up drug development

Smith & Nephew launches DYONICS RF System to remove soft tissue during arthroscopic surgery

IBM Maximo software helps GNL ensure optimal performance of equipment in fight against emerging infectious diseases

Researchers study how laser-induced ultrasound could help identify the stage of melanoma

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News